AWS GraphRAG deployment cuts drug research cycles by 87%

1Key Takeaways

• A recent AWS GraphRAG deployment reduced drug research and development cycles in pharmaceutical environments by 87 percent.
• This acceleration is achieved by integrating previously separated proprietary databases into a unified and queryable knowledge graph.
• Historically, initial data gathering and screening phases took over six months per iteration, yielding a low five percent success rate.